-
Adverse Reaction to Dilantin May be Related to Dosage Level
March 25, 2019 |Legal News, Pharmaceuticals -
FDA Warns of Stroke Risk With Taking MS Drug Lemtrada
March 20, 2019 |Legal News, Pharmaceuticals -
FDA Says Safety Trial Linked Xeljanz to Blood Clot Risk
March 20, 2019 |Legal News, Pharmaceuticals -
Viberzi Dosing Linked to Increased Risk of Pancreatitis if Gallbladder Removed
March 19, 2019 |Legal News, Pharmaceuticals -
Bone Cement Failure: What Are The Symptoms of Aseptic Loosening?
March 19, 2019 |Legal News, Pharmaceuticals -
New Gadolinium Lawsuit Filed over Dye Retention, Complications
March 19, 2019 |Legal News, Pharmaceuticals -
FDA Issues New Warning About Side Effects of Uloric Medication
March 18, 2019 |Legal News, Pharmaceuticals -
Valsartan Lawsuit Alleges Contaminated Medication Stocks Caused Stomach Cancer
March 18, 2019 |Legal News, Pharmaceuticals -
Zinbryta Serious Side Effects Prompted Complete Market Withdrawal
March 18, 2019 |Legal News, Pharmaceuticals -
Side Effects of Zinbryta Led to Withdrawal of MS Drug from US Market
March 14, 2019 |Legal News, Pharmaceuticals -
FDA Warns About Potential Viberzi and Pancreatitis Correlation
March 14, 2019 |Legal News, Pharmaceuticals -
Cerebellar Atrophy Symptoms Could Take Dilantin Users by Surprise
March 11, 2019 |Legal News, Pharmaceuticals
Pharmaceuticals
Attorneys
Work With Us
Top Class Actions has helped law firms across the country successfully find plaintiffs for class action lawsuits & mass torts since 2008, receiving tens of thousands of leads per month. We also can push your legitimate claim rate up to 25%, depending on your settlement, with our various strategies to broadcast your message.
Get in Touch













